La cadena de opciones muestra datos clave de las opciones de acciones de Eason Technology a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Eason Technology..

Eason Technology (AMEX:DXF) Bolsa, Cadena de Opciones

Dunxin Financial Hldgs

Eason Technology Ltd Formerly Dunxin Financial Holdings Ltd is engaged in the business of providing loan facilities to micro, small, and medium-sized enterprises and sole proprietors in the Hubei province of the People's Republic of China. It serves family-run businesses, farmers, and individual borrowers. Some of its loan products include Consumer Loans; Commercial Loans; Collateral-Backed Loans; Enterprise Loans, and others.

ACTU

ALVO

BACK

CSBR

EVGR

GLRE

HEPA

JDZG

JYNT

LUNG

PRTA

SRRK

UNTY

VREX

YIBO

ZKIN

IMAC Holdings sube más del 108% tras anunciar Ignite Proteomics. Conoce las acciones más destacadas en la negociación previa.

Acciones de IMAC Holdings se disparan un 108%; 20 acciones en movimiento en el premercado de EE.UU.

Eason Technology Limited American Depositary Shares (each representing sixty-thousand (60,000) Ordinary Shares)

Eason Technology Ltd

Dunxin Financial Holdings Ltd ADR

ZenaTech, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZENA#NASDAQ">ZENA</a>) (FSE: 49Q) (BMV:<a class="ticker" href="https://www.benzinga.com/stock/ZENA#BMV">ZENA</a>) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), enterprise SaaS and Quantum Computing solutions, today announces that its Taiwan subsidiary, Spider Vision Sensors, is in the process of expanding its East Asian partnerships to sell to customers in the rapidly growing government defense and commercial drone markets. The company is also expanding its partnerships with local component manufacturers to further US military compliance in manufacturing sensors, cameras and parts for its ZenaDrone 1000 and IQ series multifunction AI drones. ZenaTech has hired two business development managers with plans to add up to five engineers over the next month to join the Spider Vision Sensors office team.

News

Global

BMV:ZENA

ZENA

ZenaTech's Taiwan Subsidiary Developing Partnerships In East Asia To Sell To The Fast-Growing Defense And Commercial Drone Markets

Legal

LSPD

Lightspeed Commerce Announces United States District Court for the Eastern District of New York Dismisses In Full Securities Class Action Lawsuit Against Co.

Barclays analyst Ryan McKeveny maintains GitLab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) with a Equal-Weight and lowers the price target from $70 to $58.

Price Target

Analyst Ratings

GTLB

Barclays Maintains Equal-Weight on GitLab, Lowers Price Target to $58

Highlights:
<ul>
<li>FICO remains a leader in innovation, with advancements in decision-making, machine learning, and AI-related technology.</li>
<li>FICO's current patent portfolio consists of 226 U.S. and foreign active patents, with additional 75 patent applications filed and pending.</li>
</ul>
Global analytics software leader FICO was awarded new patents by the U.S. Patent and Trademark Office, encompassing technologies in fraud, artificial intelligence, machine learning, decision management and cybersecurity. The new patents showcase FICO's continuous innovations and leadership in operationalizing AI to deliver tangible results.
To date, FICO's patent portfolio includes over 200 U.S. and international patents. These patents represent innovative technologies aimed at helping drive profitability, customer satisfaction, customer protection, and growth across industries such as financial services, telecommunications, healthcare, retail, transportation, supply chain, and more.
The technology covered by FICO's new patents include:
<ul>
<li>A Latent-Space Misalignment Measure of Responsible AI for Machine Learning Models – This method covers technological improvements that identify misaligned data in a latent space for machine learning models. The innovation provides valuable new techniques to measure the degree of misalignment of a given data source with respect to an underlying machine learning model, both during development and production, and thereby furthers a core tenant of Responsible AI.</li>
<li>Enhanced Data Privacy Through Structure-preserving Autoencoders with Latent Space Augmentation – This is a method for generating refined (de-identified and anonymized) synthetic data from one or more sources of data.</li>
<li>Method and Apparatus for Analyzing Coverage, Bias, and Model Explanations in Large Dimensional Modeling Data - This method improves the fairness and transparency of AI models by identifying biases and weaknesses in large, complex datasets. By analyzing how AI models make decisions and the data on which they are built, it helps ensure the models are more accurate and explainable, which is crucial for building trust and accountability in AI systems.</li>
<li>Latent Feature Dimensionality Bounds for Robust Machine Learning on High Dimensional Datasets - This technology optimizes architectures of neural network models by compactly processing complex data, enhancing their stability and reliability. It helps ensure better performance when handling large, high-dimensional datasets, making machine learning models more accurate and dependable.</li>
<li>Data Distillery for Signal Detection - This system identifies important patterns or "signals" within vast datasets, helping businesses prioritize key insights to utilize in models and risk strategies. It streamlines data analysis of relevant business signals making decision management more efficient and effective.</li>
<li>Facial Recognition for User Authentication - This technology enhances user authentication by leveraging facial recognition to securely verify identities. Its integration with transaction fraud detection can strengthen the identification of potentially compromised accounts.</li>
<li>System and Method for Linearizing Messages from Data Sources for Optimized High-Performance Processing in a Stream Processing System - This technology is useful for handling large streams of real-time data, such as in financial or customer service systems.</li>
<li>Interpretable Feature Discovery with Grammar-based Bayesian Optimization - This method uses Bayesian search to discover and optimize key features in data, making machine learning models more understandable and interpretable. It helps ensure AI decisions are transparent, making it easier to trust the outcomes generated by these systems.</li>
<li>Managing Missing Values In Datasets For Machine Learning Models - This technology addresses missing data elements and handling in machine learning models by filling in gaps. It provides strategies for AI systems to remain reliable when data elements are incomplete.</li>
<li>Attributing Reasons to Predictive Model Scores - This improvement helps explain the factors that influence predictive model scores, making it easier to understand how decisions are made and providing rationale to consumers. It's particularly valuable in fraud detection systems like FICO&#xAE; Falcon&#xAE; Fraud Manager and any transaction analytic AI, ensuring transparency in transaction patterns driving outcomes and trust in scoring.</li>
<li>Cyber Security Adaptive Analytics Threat Monitoring System and Method - This system detects malware and other security threats by analyzing DNS and other network communication messages to assess threats. It provides businesses with real-time insights into potential attacks on key information and financial systems, helping them protect against cyber-attacks and data being actively infiltrated.</li>
</ul>

FICO

FICO Announces 12 New Patents, Advancing Responsible AI, Machine Learning, And Applied Intelligence Technology

<ul>
<li>Strengthens the Potential for Improved Patient Outcomes through Improvements in the Quality of Anticoagulation, Enhancing Hemocompatibility in HeartMate 3&#x2122; LVAD patients</li>
</ul>
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cadrenal.com%2F&amp;esheet=54218519&amp;newsitemid=20250304792377&amp;lan=en-US&amp;anchor=Cadrenal+Therapeutics&amp;index=1&amp;md5=849cf8be59121165ab208f7f5b1ad1c8">Cadrenal Therapeutics</a>, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVKD#NASDAQ">CVKD</a>), a late-stage biopharmaceutical company focused on the development of specialized cardiovascular therapeutics, with the late-stage asset tecarfarin, a new oral Vitamin K antagonist (VKA), today announced the signing of a Collaboration Agreement with Abbott (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) to support Cadrenal's pivotal TECarfarin Anticoagulation and Hemocompatibility with Left Ventricular Assist Devices (TECH-LVAD) trial.
Under the terms of the Collaboration and Data Sharing Agreement, Abbott will support Cadrenal on the planning and execution of the TECH-LVAD trial to evaluate the efficacy and safety of tecarfarin in patients with LVADs. Under the Agreement, Abbott will share insights from recent HeartMate 3&#x2122; trials and will support Cadrenal with: trial design, site identification, trial awareness, and HeartMate 3&#x2122; expertise.

Biotech

General

CVKD

Cadrenal Therapeutics Announces Collaboration Agreement With Abbott In Support Of Pivotal Study Of Tecarfarin In Patients With HeartMate 3 LVAD

Contracts

Xactus Announces It Has Collaborated Up With Xactus As Its First Technology Partner To Bring Its FICO Score Mortgage Simulator To Market.

908 Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASS#NASDAQ">MASS</a>) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.35) by 22.86 percent. The company reported quarterly sales of $18.82 million which beat the analyst consensus estimate of $16.39 million by 14.85 percent. This is a 31.14 percent increase over sales of $14.35 million the same period last year.

Earnings

Earnings Beats

MASS

908 Devices Q4 2024 Adj EPS $(0.27) Beats $(0.35) Estimate

JUNS

Jupiter Neurosciences And Aquanova AG To Jointly Develop Nutritional Products Targeting Longevity

Rocket Lab USA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) shares are trading lower in the premarket session on Tuesday amid weakness in anticipation of U.S. tariffs,&nbsp;<a target="_blank" href="https://www.benzinga.com/news/global/25/02/44010093/trumps-plan-for-canada-mexico-china-tariffs-to-start-march-4-could-shake-stock-market" rel="noreferrer noopener">expected to begin Tuesday</a>.&nbsp;
Meanwhile, Rocket Lab announced the launch window for its 61st Electron mission, a dedicated launch for Japanese customer the Institute for Q-shu Pioneers of Space, Inc.
The mission, named &#8220;The Lightning God Reigns,&#8221; is set to lift off from Rocket Lab Launch Complex 1 in New Zealand on March 10th UTC.
This mission will deploy the QPS-SAR-9 satellite (nicknamed &#8220;SUSANOO-I&#8221;) into a 575 km circular Earth orbit, contributing to iQPS&#8217;s expanding Earth-imaging constellation.
The satellite will enable high-resolution monitoring of specific locations every 10 minutes, supporting iQPS&#8217;s efforts to build a more robust satellite network.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/forex/25/03/44103558/asia-and-europe-markets-decline-oil-falls-as-opec-confirms-output-hike-global-markets-today-while-us-slept" rel="noreferrer noopener">Asia And Europe Markets Decline; Oil Falls As OPEC+ Confirms Output Hike &#8211; Global Markets Today While US Slept</a>
This launch marks the first of eight upcoming missions for iQPS over the next two years and is part of Rocket Lab&#8217;s larger effort to expand its launch capabilities. It also serves as the company&#8217;s third mission of 2025, taking its total number of satellites delivered to space to 211.
Recently, Rocket Lab&#8217;s shares experienced a sell-off after the company reported its<a target="_blank" href="https://www.benzinga.com/general/space/25/02/44027404/rocket-lab-q4-earnings-revenue-beat-eps-beat-new-satellite-product-multi-launch-agreement-shares-slide-on-soft-guidance" rel="noreferrer noopener"> fourth-quarter earnings last week</a>.
Despite a 121% year-over-year revenue increase to $132.39 million, Rocket Lab posted a quarterly loss of 10 cents per share, aligning with analyst expectations.
While the company exceeded revenue estimates, its first-quarter revenue guidance of $117 million to $123 million was below the consensus forecast of $135.67 million. Additionally, Rocket Lab anticipates an adjusted EBITDA loss of $33 million to $35 million for the first quarter, which contributed to the bearish market reaction.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, RKLB stock has gained over 321% in the past year. Investors can gain exposure to the stock via&nbsp;ARK Space Exploration &amp; Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKX#BATS">ARKX</a>).
Price Action: RKLB shares are trading lower by 0.59% to $18.56 premarket at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44103610/taiwan-semiconductor-doubles-down-on-us-chipmaking-165-billion-investment-set-to-reshape-tech-jobs" target="_blank" rel="noreferrer noopener">Taiwan Semiconductor Doubles Down On US Chipmaking, Plans $165 Billion Investment</a></li>
</ul>

Equities

Markets

Movers

ARKX

RKLB

What's Going On With Rocket Lab Stock Today?

Barclays analyst Benjamin Theurer maintains Fomento Economico (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMX#NYSE">FMX</a>) with a Equal-Weight and raises the price target from $99 to $102.

Fomento Economico Mexicano S.A.B. De C.V.

Barclays Maintains Equal-Weight on Fomento Economico, Raises Price Target to $102

L.B. Foster (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSTR#NASDAQ">FSTR</a>) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.28 by 107.14 percent. This is a 50 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $128.18 million which missed the analyst consensus estimate of $133.20 million by 3.77 percent. This is a 4.96 percent decrease over sales of $134.88 million the same period last year.

Earnings Misses

FSTR

L.B. Foster Q4 2024 GAAP EPS $(0.02) Misses $0.28 Estimate, Sales $128.18M Miss $133.20M Estimate

AMPG

AmpliTech Group Receives Purchase Order For Its ORAN 5G 64T64R MIMO Radio

GCTS

GSAT

GCT Semiconductor And Globalstar Enters Strategic Partnership To Develop IoT Modules For Two-Way Satellite, Cellular And Band 53 Connectivity

INDP

Indaptus Therapeutics Secures New Patent Approvals In China, Japan And Israel For Its Decoy Platform

Viant Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSP#NASDAQ">DSP</a>) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $23.25, with a high estimate of $27.00 and a low estimate of $21.00. Marking an increase of 24.53%, the current average surpasses the previous average price target of $18.67. 
<img src="https://www.benzinga.com/files/images/story/2025/1741093289_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Viant Technology. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$21.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Andrew Boone</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$24.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$21.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Nat Schindler</td>
<td>Scotiabank</td>
<td>Announces</td>
<td>Sector Outperform</td>
<td>$27.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Viant Technology. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Viant Technology compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Viant Technology's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Viant Technology's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/DSP/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Viant Technology analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind Viant Technology</h2>
Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. Through the technology, a marketer can easily buy ads on desktop, mobile, connected TV, linear TV, streaming audio and digital billboards.
<h3>A Deep Dive into Viant Technology's Financials</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Growth: Viant Technology's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 34.13%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Viant Technology's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.89% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Viant Technology's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.46% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Viant Technology's ROA excels beyond industry benchmarks, reaching 0.36%. This signifies efficient management of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.45.
<h2>The Basics of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Viant Technology Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

Throughout the last three months, 5 analysts have evaluated Medtronic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDT#NYSE">MDT</a>), offering a diverse set of opinions from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Medtronic and provided 12-month price targets. The average target is $97.4, accompanied by a high estimate of $107.00 and a low estimate of $89.00. Witnessing a positive shift, the current average has risen by 4.73% from the previous average price target of $93.00.
<img src="https://www.benzinga.com/files/images/story/2025/1741093276_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The standing of Medtronic among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joanne Wuensch</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$107.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Shagun Singh</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$105.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Danielle Antalffy</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$95.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>David Rescott</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$91.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Richard Newitter</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$89.00</td>
<td>$93.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Medtronic. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Medtronic compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Medtronic's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Medtronic's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/MDT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Medtronic analyst ratings.</a>
<h2>Delving into Medtronic's Background</h2>
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.
<h3>Unraveling the Financial Story of Medtronic</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Positive Revenue Trend: Examining Medtronic's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 2.51% as of 31 January, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Medtronic's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 15.61%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Medtronic's ROE stands out, surpassing industry averages. With an impressive ROE of 2.64%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Medtronic's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.44% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Medtronic's debt-to-equity ratio is below the industry average at 0.54, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: Simplified</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For Medtronic's Future

W.P. Carey (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WPC#NYSE">WPC</a>) underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $61.0, a high estimate of $67.00, and a low estimate of $56.00. This upward trend is evident, with the current average reflecting a 3.64% increase from the previous average price target of $58.86.
<img src="https://www.benzinga.com/files/images/story/2025/1741093266_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive W.P. Carey. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Rich Hightower</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$60.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Steve Sakwa</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$64.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>John Kim</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$67.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Brad Heffern</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$62.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Rich Hightower</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$56.00</td>
<td>$59.00</td>
</tr>
<tr>
<td>Nicholas Yulico</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$59.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Rich Hightower</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$59.00</td>
<td>$56.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to W.P. Carey. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of W.P. Carey compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of W.P. Carey's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into W.P. Carey's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/WPC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on W.P. Carey analyst ratings.</a>
<h2>Unveiling the Story Behind W.P. Carey</h2>
W.P. Carey Inc is a real estate investment trust principally involved in the ownership of properties located in the U.S., Western Europe, and Northern Europe. W.P. Carey organizes its operations into Real Estate and Investment Management segments. The vast majority of the company's income is derived from its Real Estate division in the form of lease revenue from long-term agreements with companies. W.P. Carey's real estate portfolio is primarily comprised of single-tenant office, industrial, warehouse, and retail facilities located around the world. majority of the company's revenue comes from properties in the USA. Its Investment Management unit generates revenue from providing real estate advisory and portfolio management services to other REITs.
<h3>W.P. Carey: A Financial Overview</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Decline in Revenue: Over the 3 months period, W.P. Carey faced challenges, resulting in a decline of approximately -1.52% in revenue growth as of 31 December, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Real Estate sector.
Net Margin: W.P. Carey's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 11.58%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): W.P. Carey's ROE stands out, surpassing industry averages. With an impressive ROE of 0.55%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.27%, the company showcases effective utilization of assets.
Debt Management: W.P. Carey's debt-to-equity ratio is below the industry average. With a ratio of 0.95, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>What Are Analyst Ratings?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Assessing W.P. Carey: Insights From 7 Financial Analysts

Eversource Energy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ES#NYSE">ES</a>) short percent of float has risen 24.56% since its last report. The company recently reported that it has 6.04 million shares sold short, which is 2.13% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.86 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Eversource Energy Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741093260_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Eversource Energy has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Eversource Energy's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Eversource Energy's peer group average for short interest as a percentage of float is 2.50%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Is Eversource Energy Gaining or Losing Market Support?

Affiliated Managers Group's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMG#NYSE">AMG</a>) short percent of float has risen 36.1% since its last report. The company recently reported that it has 818 thousand shares sold short, which is 3.77% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.71 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Affiliated Managers Group Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741093254_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Affiliated Managers Group has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Affiliated Managers Group's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Affiliated Managers Group's peer group average for short interest as a percentage of float is 3.25%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Affiliated Managers Group's Recent Short Interest

Throughout the last three months, 6 analysts have evaluated Chart Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTLS#NYSE">GTLS</a>), offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $207.67, a high estimate of $231.00, and a low estimate of $165.00. Observing a 17.77% increase, the current average has risen from the previous average price target of $176.33. 
<img src="https://www.benzinga.com/files/images/story/2025/1741093251_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Chart Industries. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Anderson</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$165.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$214.00</td>
<td>$215.00</td>
</tr>
<tr>
<td>Scott Gruber</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$225.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Benjamin Nolan</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$231.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Ati Modak</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$201.00</td>
<td>$138.00</td>
</tr>
<tr>
<td>Gregory Lewis</td>
<td>BTIG</td>
<td>Raises</td>
<td>Buy</td>
<td>$210.00</td>
<td>$170.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Chart Industries. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Chart Industries compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Chart Industries's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/GTLS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Chart Industries analyst ratings.</a>
<h2>All You Need to Know About Chart Industries</h2>
Chart Industries provides a variety of cryogenic equipment for storage, distribution, and other processes within the industrial gas and liquefied natural gas industries. It also provides natural gas processing solutions for the natural gas industry and specialty products that serve a variety of spaces, including hydrogen, biofuels, cannabis, and water treatment. The firm acquired Howden in a significant deal in early 2023, roughly doubling the size of the company.
<h3>Chart Industries: Financial Performance Dissected</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Chart Industries's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 9.04%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Chart Industries's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 6.58%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Chart Industries's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 2.51%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Chart Industries's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.78%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Chart Industries's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.29, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GTLS

A Glimpse Into The Expert Outlook On Chart Industries Through 6 Analysts

Fintech

Press Releases

Dunxin Financial Holdings Limited Announces NYSE American Notice of Delisting

Real Estate

Dunxin Financial Holdings Limited Announces Management Changes

Dunxin Financial Holdings Limited Announces Planned Name Change to Eason Technology Limited and 2024 Annual General Meeting of Shareholders

Small Cap

Dunxin Financial Holdings Limited Announces $162,500 Convertible Promissory Note Private Placement

Dunxin Financial Holdings Limited Announces Planned ADS Ratio Change

Dunxin Financial Holdings Limited Announces Name Change to Eason Technology Limited

Eason Technology Limited Announces NYSE American Removal of Trading Suspension

Eason Technology Limited Announces Acquisition of Blockchain Technology Company

Eason Technology Securres HK $1.5 Million in Funding to Accelerate Blockchain Intellectual Property Protection Development

Eason Technology Plans to Purchase Bitcoin to Accelerate R&D of Digital Asset Security Products

Comments

Eason Technology

Eason Technology (DXF) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL